BRTX - BioRestorative Therapies, Inc.
1.8
0.020 1.111%
Share volume: 10,320
Last Updated: 05-07-2025
Healthcare/Services – Health:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.78
0.02
0.01%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 06-11-2024 | 08-11-2023 | 11-13-2023 | 11-12-2024 | 06-11-2024 | 08-13-2024 | 11-12-2024 | 03-28-2025 | |
Total revenue | 31.300 K | 64.500 K | 30.700 K | 19.300 K | 35.000 K | 89.100 K | 233.600 K | 43.300 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 6.490 K | 18.243 K | 3.339 K | |
Gross profit | 31.300 K | 64.500 K | 30.700 K | 19.300 K | 35.000 K | 82.610 K | 215.357 K | 39.961 K | |
106.07% | -52.40% | -37.13% | 81.35% | 136.03% | 160.69% | -81.44% | |||
Operating expenses | 5.810 M | 3.181 M | 3.135 M | 3.240 M | 4.144 M | 2.551 M | 2.502 M | 2.730 M | |
Selling general and admin | 4.579 M | 2.278 M | 2.325 M | 2.215 M | 3.086 M | 1.259 M | 1.182 M | 1.052 M | |
Research and development | 1.232 M | 902.891 K | 809.824 K | 1.025 M | 1.058 M | 1.292 M | 1.320 M | 1.678 M | |
Total expenses | 5.810 M | 3.181 M | 3.135 M | 3.240 M | 4.144 M | 2.551 M | 2.502 M | 2.730 M | |
-45.25% | -1.44% | 3.34% | 27.91% | -38.43% | -1.92% | 9.10% | |||
Operating income | -5.779 M | -3.117 M | -3.104 M | -3.221 M | -4.109 M | -2.469 M | -2.287 M | -2.690 M | |
Ebit | -7.191 M | -5.806 M | 4.707 M | 5.014 M | -2.386 M | -4.205 M | -1.250 M | -1.755 M | |
Pretax income | -7.173 M | -5.709 M | 4.768 M | 5.390 M | -2.223 M | -4.029 M | -1.091 M | -1.636 M | |
-20.40% | -183.52% | 13.03% | -141.25% | 81.20% | -72.91% | 49.91% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -7.173 M | -5.709 M | 4.768 M | 5.390 M | -2.223 M | -4.029 M | -1.091 M | -1.636 M | |
20.40% | 183.52% | 13.03% | -141.25% | -81.20% | 72.91% | -49.91% |